KindlyMD secures a major $210M USDT loan from Kraken, marking a significant financing event within the firm’s Bitcoin-focused strategy. KindlyMD revealed a major financial move on Tuesday as its subsidiary secured a sizable loan from Kraken. The news caught the attention of markets as this facility tops the company’s facility valuation and helps the firm’s […] The post Kraken Grants One-Year $210M USDT Loan to KindlyMD Subsidiary appeared first on Live Bitcoin News.KindlyMD secures a major $210M USDT loan from Kraken, marking a significant financing event within the firm’s Bitcoin-focused strategy. KindlyMD revealed a major financial move on Tuesday as its subsidiary secured a sizable loan from Kraken. The news caught the attention of markets as this facility tops the company’s facility valuation and helps the firm’s […] The post Kraken Grants One-Year $210M USDT Loan to KindlyMD Subsidiary appeared first on Live Bitcoin News.

Kraken Grants One-Year $210M USDT Loan to KindlyMD Subsidiary

2025/12/10 15:00

KindlyMD secures a major $210M USDT loan from Kraken, marking a significant financing event within the firm’s Bitcoin-focused strategy.

KindlyMD revealed a major financial move on Tuesday as its subsidiary secured a sizable loan from Kraken. The news caught the attention of markets as this facility tops the company’s facility valuation and helps the firm’s ongoing bitcoin treasury effort via Nakamoto holdings.

Loan Deal Highlights Generate Market Interest

According to the recent SEC filing, Nakamoto Holdings on December 9 closed a $210 million USDT loan with Kraken. The agreement includes a one-year fixed term, an 8% annual rate of fee, and a December 4, 2026, maturity.

Related Reading: Kraken and Deutsche Börse Partner to Unify Crypto and Stock Trading | Live Bitcoin News

Additionally, the loan value is above KindlyMD’s market cap of almost $198.94 million. This gap highlights the financial burden of the deal, and arouses new debate among analysts. Market references also reference similarities against historical filings with individual lenders additional and making context of the firm’s ongoing debt strategy.

Market Background Reveals Growing Treasury Plans

KindlyMD previously had a $203 million term loan deal with Two Prime Lending Limited. That debt formed a large portion of its enterprise value, which came to about $635.9 million in late September. Different reports and blogs in the past have already pointed out an aggressive strategy on debt-supported growth.

What’s more, KindlyMD received a merger with Nakamoto Holdings that was completed in August. This step turned the once healthcare firm into a bitcoin treaty operator. The company gained the strategy on which it heavily depends on loans to increase its digital asset reserves, which strengthens earlier projections presented in community research posts.

By the end of September, the company bought 5765 BTC at $118,204 on average. After investing a total of 367 BTC, it seems that KindlyMD was left with 5,389 BTC by mid-November. These figures can be seen in a number of public disclosures and bolster the story of a concentrated treasury expansion.

KindlyMD secures a major $210M USDT loan from Kraken, marking a significant financing event within the firm’s Bitcoin-focused strategy.Source: SEC

Moreover, analysts believe the Kraken loan will support other acquisitions of BTC. This view is consistent with recent discussions in industry blogosphere on large size loan facilities being consistent with continued accumulation strategies. Consequently, this financing round could position KindlyMD in a better competitive position in the digital asset treasury space.

KindlyMD’s BTC Exposure Sparks Debate Over Treasury Stability

In addition, experts underscore that transitions in periods after huge debt deals tend to determine future valuation conditions. Therefore, a balance between the loan obligations and the movement in the BTC market will be a determining factor in the financial stability of the firm over the next year.

Consequently, the balance sheet of the firm will keep being closely linked to the price volatility of BTC. Increasing leverage may increase sensitivity to the forced liquidation risks in the event of market declines. Market commentators warn that such conditions also may put pressure on liquidity buffers because debt obligations are maturing.

Furthermore, the magnitude of the Kraken loan places KindlyMD in a high-stakes context where asset values, loan terms and actions in treasury must play nicely together. This dynamic will probably determine the company in the near future and will determine the broader discussions on the topic of crypto-treasury sustainability.

The post Kraken Grants One-Year $210M USDT Loan to KindlyMD Subsidiary appeared first on Live Bitcoin News.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

China Blocks Nvidia’s RTX Pro 6000D as Local Chips Rise

China Blocks Nvidia’s RTX Pro 6000D as Local Chips Rise

The post China Blocks Nvidia’s RTX Pro 6000D as Local Chips Rise appeared on BitcoinEthereumNews.com. China Blocks Nvidia’s RTX Pro 6000D as Local Chips Rise China’s internet regulator has ordered the country’s biggest technology firms, including Alibaba and ByteDance, to stop purchasing Nvidia’s RTX Pro 6000D GPUs. According to the Financial Times, the move shuts down the last major channel for mass supplies of American chips to the Chinese market. Why Beijing Halted Nvidia Purchases Chinese companies had planned to buy tens of thousands of RTX Pro 6000D accelerators and had already begun testing them in servers. But regulators intervened, halting the purchases and signaling stricter controls than earlier measures placed on Nvidia’s H20 chip. Image: Nvidia An audit compared Huawei and Cambricon processors, along with chips developed by Alibaba and Baidu, against Nvidia’s export-approved products. Regulators concluded that Chinese chips had reached performance levels comparable to the restricted U.S. models. This assessment pushed authorities to advise firms to rely more heavily on domestic processors, further tightening Nvidia’s already limited position in China. China’s Drive Toward Tech Independence The decision highlights Beijing’s focus on import substitution — developing self-sufficient chip production to reduce reliance on U.S. supplies. “The signal is now clear: all attention is focused on building a domestic ecosystem,” said a representative of a leading Chinese tech company. Nvidia had unveiled the RTX Pro 6000D in July 2025 during CEO Jensen Huang’s visit to Beijing, in an attempt to keep a foothold in China after Washington restricted exports of its most advanced chips. But momentum is shifting. Industry sources told the Financial Times that Chinese manufacturers plan to triple AI chip production next year to meet growing demand. They believe “domestic supply will now be sufficient without Nvidia.” What It Means for the Future With Huawei, Cambricon, Alibaba, and Baidu stepping up, China is positioning itself for long-term technological independence. Nvidia, meanwhile, faces…
Share
BitcoinEthereumNews2025/09/18 01:37